How much cash does Strata Critical Medical, Inc. Class A Common Stock generate?

Strata Critical Medical, Inc. Class A Common Stock (SRTA) generated -$44.8M in operating cash flow over the trailing twelve months.

What is Strata Critical Medical, Inc. Class A Common Stock's free cash flow?

After $12.2M of capital expenditures, Strata Critical Medical, Inc. Class A Common Stock's free cash flow was -$56.9M over the trailing twelve months, down 186.5% year over year.

Where does Strata Critical Medical, Inc. Class A Common Stock's cash flow data come from?

Every line is extracted from Strata Critical Medical, Inc. Class A Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Strata Critical Medical, Inc. Class A Common Stock SRTA Cash Flow Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Net income	——	——	$40.39M+313%	-$18.98M+28.5%	-$26.57M+2.7%
Depreciation and amortization	$9.55M+16.7%	$8.19M+22.0%	$6.71M+6.8%	$6.28M+3.6%	$6.07M+1.7%
Stock-based compensation	$18.65M+4.6%	$17.83M+13.1%	$15.77M-19.1%	$19.49M-1.5%	$19.79M-0.5%
Deferred income taxes	——	——	$453K+307%	-$219K—	——
Gain (loss) on sale of assets	——	——	——	——	$0—
Change in accounts receivable	$11.37M-5.6%	$12.03M—	——	——	——
Change in accounts payable	——	——	$8.39M+8,210%	$101K—	——
Change in other assets	-$731K-9.8%	-$666K-540%	-$104K-123%	$462K+3,454%	$13K-81.4%
Other working capital changes	——	——	——	——	$413K+27.9%
Change in deferred revenue	——	——	——	——	——
Net cash from operating activities	-$44.78M+8.4%	-$48.91M-15.5%	-$42.36M—	——	——
Capital expenditures	$12.16M+26.7%	$9.6M-22.1%	$12.32M-34.5%	$18.8M-42.4%	$32.66M+5.8%
Proceeds from maturities/sales of investments	——	——	——	$48.56M+869%	$5.01M—
Purchases of intangible assets	$1.19M-16.3%	$1.42M-17.6%	$1.72M-15.2%	$2.02M-13.5%	$2.34M+10.4%
Purchases of fixed maturity securities	$62.06M-57.6%	$146.26M-0.3%	$146.75M-9.8%	$162.61M+8.1%	$150.4M+5.0%
Net cash from investing activities	$74.07M+6.2%	$69.75M—	——	——	——
Proceeds from issuance of common stock	$185K-4.1%	$193K+5.5%	$183K+41.9%	$129K-5.8%	$137K-18.5%
Taxes paid for net share settlement	$5.38M-40.9%	$9.11M-18.9%	$11.23M+11.0%	$10.12M+1.7%	$9.95M+75.1%
Payment of debt issuance costs	——	——	——	——	——
Net cash from financing activities	-$5.53M+38.0%	-$8.91M+19.3%	-$11.04M-10.6%	-$9.99M+0.7%	-$10.06M-74.7%
Effect of exchange rate changes on cash	-$465K-37.2%	-$339K+24.3%	-$448K-295%	$230K+219%	$72K+190%
Net increase (decrease) in cash	——	——	——	$31.95M+1,447%	-$2.37M+74.7%
Accretion (Amortization) of Discounts and Premiums, Investments	$1.76M-20.7%	$2.21M-14.9%	$2.6M-18.7%	$3.2M-1.0%	$3.23M-19.0%
Change in fair value of other assets and liabilities	——	——	——	——	$0—
Gain on sale of business and assets	——	——	——	——	——
Increase (Decrease) in Operating Lease Assets And Liabilities	-$13K-114%	$90K+1,186%	$7K+111%	-$64K+60.2%	-$161K+1.8%
Increase (Decrease) in Prepaid Expense and Other Assets	$3.56M+111%	$1.69M—	——	——	——
Payment of seller transaction costs	——	$44.34M+33.3%	$33.25M+50.0%	$22.17M+100%	$11.08M—
Impairment of long-lived assets	——	$1.67M+33.3%	$1.25M+50.0%	$836.5K+100%	$418.25K—
Payments to Acquire Held-to-Maturity Securities	$62.06M-57.6%	$146.26M-0.3%	$146.75M-9.8%	$162.61M+8.1%	$150.4M+5.0%
Payments to Acquire Intangible Assets	$1.19M-16.3%	$1.42M-17.6%	$1.72M-15.2%	$2.02M-13.5%	$2.34M+10.4%
Transaction Costs Paid Related to Sale Of Business, Cash Transfer	——	——	——	——	——
Payments Of Debt Issuance Costs	——	——	——	——	——
Accrued payables for capital expenditures	——	——	——	——	——
Fair Value Adjustment Of Warrants	-$2.99M+30.2%	-$4.28M-1,784%	$254K-56.7%	$586K-62.8%	$1.58M+85.4%
Increase Decrease In Contract With Customer Liability	——	——	——	——	——
New leases under ASC 842 entered into during the period	$2.31M+44.4%	$1.6M0.0%	$1.6M-52.8%	$3.39M-48.5%	$6.57M-23.1%
Modification of existing right-of-use assets ("ROU") and lease liability	——	$0-100%	$3.17M-50.0%	$6.34M-33.3%	$9.51M-25.0%
Free cash flow	-$56.94M+2.7%	-$58.51M-7.0%	-$54.68M-212%	-$17.51M+11.9%	-$19.87M+40.5%
Free cash flow	-$56.94M+2.7%	-$58.51M-7.0%	-$54.68M-212%	-$17.51M+11.9%	-$19.87M+40.5%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Strata Critical Medical, Inc. Class A Common Stock.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

How much cash does Strata Critical Medical, Inc. Class A Common Stock generate?: Strata Critical Medical, Inc. Class A Common Stock (SRTA) generated -$44.8M in operating cash flow over the trailing twelve months.
What is Strata Critical Medical, Inc. Class A Common Stock's free cash flow?: After $12.2M of capital expenditures, Strata Critical Medical, Inc. Class A Common Stock's free cash flow was -$56.9M over the trailing twelve months, down 186.5% year over year.
Where does Strata Critical Medical, Inc. Class A Common Stock's cash flow data come from?: Every line is extracted from Strata Critical Medical, Inc. Class A Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.